Cilostazol use is associated with FIM cognitive improvement during convalescent rehabilitation in patients with ischemic stroke: a retrospective study

Cilostazol is a phosphodiesterase III-inhibiting antiplatelet agent that is often used to prevent stroke and peripheral artery disease, and its administration has shown significant improvements for cognitive impairment. We investigate the potential of cilostazol for reducing or restoring cognitive d...

Descripción completa

Detalles Bibliográficos
Autores principales: Senda, Joe, Ito, Keiichi, Kotake, Tomomitsu, Kanamori, Masahiko, Kishimoto, Hideo, Kadono, Izumi, Nakagawa-Senda, Hiroko, Wakai, Kenji, Katsuno, Masahisa, Nishida, Yoshihiro, Ishiguro, Naoki, Sobue, Gen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nagoya University 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728194/
https://www.ncbi.nlm.nih.gov/pubmed/31579328
http://dx.doi.org/10.18999/nagjms.81.3.359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728194/
https://www.ncbi.nlm.nih.gov/pubmed/31579328
http://dx.doi.org/10.18999/nagjms.81.3.359

Ejemplares similares